Is Conmed Corp (CNMD) a Bargain After 6.0% Drop? GF Value Says UndervaluedGuruFocus · Oct 6, 2026
CONMED Corporation to Report Third Quarter 2026 Financial Results on October 28, 2026Business Wire · Oct 1, 2026
Here's Why You Should Retain CONMED Stock in Your Portfolio for NowZacks Investment Research · Sep 16, 2026
Canada Pension Plan Investment Board Buys Shares of 13,800 CONMED Corporation $CNMDDefense World · Sep 3, 2026
Conmed (CNMD) Up 7.1% Since Last Earnings Report: Can It Continue?Zacks Investment Research · Aug 28, 2026
CONMED Corporation to Participate in the Wells Fargo 21st Annual Healthcare ConferenceBusiness Wire · Aug 26, 2026CONMED Corporation functions as a medical technology enterprise, specializing in the global development, production, and distribution of surgical instruments and related apparatus for a variety of surgical procedures. Its comprehensive product portfolio includes specialized orthopedic surgical items, such as the TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-Knot All-Suture Anchors, and PopLok Knotless Suture Anchors. These innovative offerings provide unique clinical advantages to orthopedic surgeons for repairing soft tissue injuries and are complemented by supportive tools that facilitate minimally invasive sports medicine operations.
| Date | Est. | Actual | |
|---|---|---|---|
| Jul 29, 2026 | $1.11 | $1.38 | Beat |
| Apr 29, 2026 | $0.82 | $0.89 | Beat |
| Jan 28, 2026 | $1.32 | $1.43 | Beat |
| Nov 5, 2025 | $1.05 | $1.08 | Beat |
| Jul 30, 2025 | $1.13 | $1.15 | Beat |
| Apr 30, 2025 | $0.81 | $0.95 | Beat |